Evercore ISI analyst Vijay Kumar lowered the firm’s price target on Medtronic (MDT) to $106 from $108 and keeps an Outperform rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDT:
- Medtronic price target lowered to $110 from $117 at Citi
- Medtronic: MiniMed IPO Dilution and Diabetes Spin-Off Limit Near-Term Upside, Justifying Hold Rating
- Medtronic price target lowered to $95 from $105 at Stifel
- Medtronic price target lowered to $115 from $125 at Argus
- Medtronic price target lowered to $108 from $115 at Evercore ISI